Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects
about
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient miceLocomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis.Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in miceEstimating neurotransmitter kinetics with ntPET: a simulation study of temporal precision and effects of biased data.Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.Striatal dopamine neurotransmission: regulation of release and uptakeLithium long-term treatment in mood disorders: clinical and genetic predictors.Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditionsCholinergic modulation of cognition: insights from human pharmacological functional neuroimagingPositron emission tomography and single-photon emission computed tomography in central nervous system drug development.Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomographyTowards a muscarinic hypothesis of schizophrenia.Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging.The dopaminergic basis of human behaviors: A review of molecular imaging studies.The cholinergic system and neostriatal memory functions.Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.Physostigmine reversal of scopolamine-induced hypofrontality.Absolute quantification by positron emission tomography of the endogenous ligand.Facilitation of dopaminergic neural transmission does not affect [(11)C]SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D(1) receptors: PET studies in the conscious mDemonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique.Central muscarinic acetylcholine receptor availability in patients treated with clozapine.Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine.Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?Evidence for striatal dopamine release during a video game.Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices.Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding.Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.
P2860
Q28587873-72FD478B-EEAA-4300-AF69-3B9A1D81BA31Q30405597-02B0F8A5-E4A1-4607-A225-FBF25252A8B4Q30444290-F25E21B6-5AF0-4657-A6E6-8832A49421ABQ31137052-257A5F44-842C-4588-9506-02708F33A0B1Q33714879-CDC5FF88-D495-4B5F-9E96-DB831CAE6531Q34229087-31731172-E431-4F65-A8C2-5B8BC59B1009Q34258319-57D59642-50E2-41B2-BF8F-3C3AD767CF2DQ34524803-0412CBEE-5E93-43CD-8240-B799B71E0B97Q34609171-DFF5EEC2-8B53-4820-A2A9-7543174B061FQ36042479-EA78C8BF-925E-426B-A048-D5C07CDD75E7Q36057102-8FCC319C-DAA1-44C2-BBFB-F5C1BF87FFE1Q36129732-7E6E6BB6-615E-4CEA-A67F-A50B8CCA12F0Q36198578-73791858-6B04-45BA-8606-FFF2E92EB780Q36673957-92B04B03-F7A0-4895-8E87-FF8CCFC25521Q36873099-560460C8-5AF1-48CA-B126-E0E0AFCC0C71Q37500893-6AC3FC61-4A24-4EC9-8ADA-3E97AD538F0CQ37815578-0FB272C8-06BD-415D-B165-8D3E21119F75Q38019926-54DCB703-14A4-452B-9DF8-6AF94DC9471DQ38150484-D325D455-2D8A-4EED-9946-97CAC95F0100Q38820233-715651AD-42CA-4472-9604-E31D2461242EQ42551090-B946BC24-20F4-4586-BFBE-2D0B689FD0EFQ43595525-1EAE285A-6634-47A7-B060-10315563747AQ43825614-C11A4C7E-A634-4A88-B819-A6FF5DF7B2FDQ43884686-4BC71625-6CB0-4F3B-A697-BEB7A4C23F7FQ44473775-48C82522-7849-4A77-8A11-064FBB120A7EQ44531006-E79453AA-EFB1-4DA8-810B-251376BD7EA4Q48374284-9B35E3BA-69BC-4C2C-9F44-E2488BD0F01FQ48458659-E5ED498A-70FE-4E92-B2AE-6E64527C1B28Q48466159-D6B43AB8-9161-4B69-A193-A87B84459734Q49065832-100F64C2-292F-4A0A-A957-F8E2EAF2FF66Q51433667-EEC08036-1515-4665-B07C-C79BE18A8A4FQ52654822-9B4C2535-4E0B-4B88-A518-0EBBC00A4719
P2860
Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Effects of central cholinergic ...... raphy in normal human subjects
@ast
Effects of central cholinergic ...... raphy in normal human subjects
@en
type
label
Effects of central cholinergic ...... raphy in normal human subjects
@ast
Effects of central cholinergic ...... raphy in normal human subjects
@en
prefLabel
Effects of central cholinergic ...... raphy in normal human subjects
@ast
Effects of central cholinergic ...... raphy in normal human subjects
@en
P2093
P2860
P356
P1476
Effects of central cholinergic ...... raphy in normal human subjects
@en
P2093
J S Fowler
N D Volkow
P Simkowitz
R R MacGregor
P2860
P304
11816-11820
P356
10.1073/PNAS.90.24.11816
P407
P577
1993-12-01T00:00:00Z